Moleculin Biotech Plunges 33% on Dilutive Financing
Moleculin Biotech, Inc. (MBRX) sank 32.50%, leading losses in the PRISM Emerging Pharmaceuticals Index, after announcing a $6.0 million capital raise through the immediate exercise of warrants. While the deal provides fresh cash to support its clinical pipeline targeting hard-to-treat tumors and viruses, the issuance of over 16M new shares and additional warrants spooked investors with dilution concerns.
Mobix Labs Rallies 21% on Military Drone Connector Wins
Mobix Labs, Inc. (MOBX) jumped 20.53% to lead the PRISM Emerging Space Index after announcing it has secured design wins and begun shipments of its advanced filtered Mil-Spec circular connectors for next-generation military drone platforms. These connectors, equipped with Pi filtering technology, are designed to suppress electromagnetic interference and ensure secure communications in contested electronic warfare environments. Management emphasized the growing demand for reliable, secure defense technologies as drones expand their role in modern battlefield operations.
Other PRISM Mid-Day Movers:
- IceCure Medical Ltd. (ICCM) up 24.86%
- Aethlon Medical, Inc. (AEMD) up 19.18%
- Relmada Therapeutics, Inc. (RLMD) up 19.10%
- Canopy Growth Corporation (CGC) up 17.87%
The post PRISM Mid-Day Movers: Pharma Pressures and Defense Tech Momentum appeared first on PRISM MarketView.
